Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Murine Model of Dilated Cardiomyopathy
2011

Exenatide Improves Glucose Homeostasis and Prolongs Survival in a Mouse Model of Heart Failure

Sample size: 9 publication 10 minutes Evidence: moderate

Author Information

Author(s): Vyas Arpita Kalla, Yang Kai-Chien, Woo Dennis, Tzekov Anatoly, Kovacs Attila, Jay Patrick Y., Hruz Paul W.

Primary Institution: Washington University School of Medicine

Hypothesis

Can pharmacologic enhancement of insulin sensitivity and myocardial glucose uptake preserve cardiac function and survival in heart failure?

Conclusion

Exenatide treatment improves glucose tolerance, cardiac function, and survival in mice with dilated cardiomyopathy.

Supporting Evidence

  • Exenatide improved glucose tolerance in TG9 mice.
  • Cardiac function was significantly better in exenatide-treated mice.
  • Survival was prolonged in exenatide-treated mice compared to controls.

Takeaway

This study shows that a diabetes drug called exenatide helps mice with heart problems by making their bodies better at using sugar and helps them live longer.

Methodology

Exenatide was administered to TG9 mice starting at 56 days of age, and glucose tolerance, cardiac function, and survival were assessed.

Limitations

The study is limited to a mouse model, and results may not directly translate to humans.

Participant Demographics

TG9 mice, a transgenic model of dilated cardiomyopathy.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017178

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication